ROME Therapeutics
is a Massachusetts-based biopharmaceutical company that researches and develops genome-based therapies for the treatment of cancer and autoimmune diseases... Read moreROME Therapeutics
is a Massachusetts-based biopharmaceutical company that researches and develops genome-based therapies for the treatment of cancer and autoimmune diseases... Read more
News
Mar 03, 2025
GlobalNewswire
Press Release: ROME Therapeutics : ROME Therapeutics Announces Publication in Nature Communications of First Large-Scale, Pan-Cancer Analysis of LINE-1 Expression Levels and Retrotransposon Activity
Nov 07, 2024
Benzinga
ROME Therapeutics: ROME Therapeutics to Present Data Supporting LINE-1 Reverse Transcriptase Inhibitors as a Novel Treatment for Autoimmune Diseases at ACR Convergence 2024
Oct 08, 2024
Benzinga
ROME Therapeutics: ROME Therapeutics, Enara Bio, Nucleome Therapeutics and NYU Langone Health to Host 3rd Annual Dark Genome Symposium
Sep 11, 2024
Benzinga
ROME Therapeutics: ROME Therapeutics to Participate in 2024 Cantor Global Healthcare Conference
Feb 29, 2024
Acrofan
ROME Therapeutics: ROME Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
Nov 16, 2023
Business Wire
Press Release: ROME Therapeutics : ROME Therapeutics Presents First Data to Validate LINE-1 RT as a Novel Target in Autoimmune Diseases and the Therapeutic Potential of its First-in-Class LINE-1 RT Inhibitors
Nov 01, 2023
GlobalNewswire
Press Release: ROME Therapeutics : Enara Bio, ROME Therapeutics and Nucleome Therapeutics to Host 2nd Annual Dark Genome Symposium
Sep 12, 2023
The Business Journals
ROME Therapeutics: Bristol Myers, J&J invest in Boston biotech's $72M VC round
Sep 12, 2023
BioPharma Dive
ROME Therapeutics: With latest fundraise, Rome Therapeutics works to drug the 'dark genome'
Sep 12, 2023
Pharamceutical Technology
ROME Therapeutics: J&J and BMS invest in dark genome-focused company Rome Therapeutics
ROME Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10